Answers are grounded in this paper and cite their sources.
Dear editor, Repositioning, repurposing or reusing drugs is currently a promising strategy against several diseases since it allows the use of existing drugs in the clinic for new therapeutic indications.1,2 Nowadays, there is a growing investigation of the various actions that Cannabis sativa, popularly known as marijuana, can exhibit. In this sense, we present a brief reflection on the feasibility of repositioning this substance. Cannabis sativa, an herbaceous plant belonging to the Cannabiaceae family, has compounds known as cannabinoids (CNB), the most abundant of which are delta9tetrahydrocannabinol (THC) and cannabidiol (CBD),3 which have the same molecular formula: 21 carbon atoms, 30 hydrogen atoms and 2 oxygen atoms (C21H30O2). A small difference in the way atoms are arranged explains the different effects on the organism. While THC contains a cyclic ring, CBD contains a hydroxyl group. It is this difference in molecular structure that provides two compounds with distinct pharmacological properties.4 Tetrahydrocannabinol, considered a psychotropic chemical, stands out for its harmful and neurotoxic effects, in addition to being responsible for recreational use and dependence on the psychoactive effects caused by the use of marijuana. CBD, on the other hand, is nonpsychotropic and acts by protecting neurons from THCinduced degeneration, being used for treating some diseases, such as multiple sclerosis, cancer and Tourette syndrome.3,5 The medicinal properties of C. sativa were reported over 4000 years ago in China, due to its numerous biologically active compounds.3 However, the cognitive impairments that the use of this substance can cause have also been known for years. Cannabis sativa is the most used illicit drug in the world, being considered a gateway to the use of several other substances of abuse and dependence, such as cocaine and heroin.4 The consumption of illicit drugs develops intense avidity on the part of the patient, resulting in daily and chronic consumption.6 The cannabinoids present in C. sativa can cross the placenta and breast milk, directly influencing neurodevelopment in the first few months of the baby's life,7 which can cause behavioural problems, impaired cognition and reduced learning.8,9 Epidemiological studies have consistently shown that cannabis use during adolescence is linked to an increased risk of psychotic symptoms, anxiety, and in some cases, depression. The association between Cannabis use and the development of neurological problems should particularly consider cumulative exposure to this drug, as adolescence is a period of brain development, as well as decisionmaking, learning, memory, emotion, motivation and reward.10 A review published in Biological Psychiatry, one of the most prestigious psychiatric journals, highlighted the brain changes found in longterm marijuana users (2 and 23 years of followup), reporting that the most affected brain areas had decreased volume and density of grey matter in the hippocampus.6 Recently, experts have reported that analyses conducted over the last few decades show a significant decrease in CBD and an increase in THC in new variants of C. sativa. Over the past 40 years, the THC content of C. sativa has steadily increased worldwide, with the average THC in 2009 being more than nine times higher compared to 1970.11 Also, extremely potent concentrations of Cannabis and decreased levels of cannabidiol present in the new legal marijuana markets located in the United States and United Kingdom were found.12– 15
No takes yet. Share an insight, caveat, or question.
Foletto et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: